Project Review: Case Study White Paper Technology Overview Healthcare Manufacturing Pharmaceutical Portfolio Government Logistics Financial Business Client Genre Vertical Evaluation of Discovery Strategic Investment Options ProModel Pharmaceutical Solutions pharmaVAO@promodel.com 888.437.0925 www.promodel.com Objectives Solution Situation Results A leading global pharmaceutical firm The firm invests close to $1 billion per year in Discovery Research to fuel the development pipeline with valuable drug opportunities. Appropriate allocation of these funds is critical to sustaining profitability. Because the business is so highly variable and unpredictable, management is always looking for more accurate ways to evaluate how various investment options affect the ability of Discovery t

Join for free to read